Remove Clinical Practice Remove Complication Remove Healthcare Professional Remove Screening
article thumbnail

Expert Panel Unveils Preanesthesia Cannabis Use Assessment Tool

Physician's Weekly

An expert panel has created a preoperative cannabis use assessment tool to aid healthcare professionals in planning informed, individualized anesthesia and analgesia care for patients. The tool should be incorporated in clinical practice,” the study team concluded, “and subsequent validation studies are needed.”

article thumbnail

Screening for Dementia: A Podcast with Anna Chodos, Joseph Gaugler and Soo Borson

GeriPal

Summary Transcript Summary The US Preventive Services Task Force (USPSTF) concluded back in 2000 that there is insufficient evidence to recommend for or against routine screening for dementia in older adults. If so, how do we screen and who do we screen? What should we use to screen individuals? Cognitive screening.

Screening 120
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

Join us as we dive deeper into these studies and discuss the implications for clinical practice and patient care. And there’s so much work on, you know, you’ve got to take these medicines, you got to prevent this treat, that there isn’t that same sort of clinical momentum towards deprescribing. Alex 15:36 Yeah.

article thumbnail

Urinary Incontinence Revisited: George Kuchel & Alison Huang

GeriPal

And it’s also hard because oftentimes people don’t even bring this up in clinic. Do you screen for lower urinary tract symptoms, incontinence, and if so, how? Eric 11:57 In, let’s say, my clinic. Alex 13:24 Eric is pushing on the like, the clinical, practical stuff. Eric 08:05 Yeah.

IT 121
article thumbnail

Anxiety in Late Life and Serious Illness: A Podcast with Alex Gamble and Brianna Williamson

GeriPal

We then walk through how we should screen for anxiety and how we should think about a differential. The question I would ask is, how helpful is that in our clinical practice? So we put those cutoffs, and I asked the question earlier, how helpful are those cutoffs in clinical practice?

Illness 130
article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. Alex: It’s complicated. We, for very complicated reasons, ended up with niacin. Stacy: We’re using anxiety, baseline anxiety, as our screening. So, creating a- Alex: Control condition.

article thumbnail

Dignity at the End of Life: A Podcast with Harvey Chochinov

GeriPal

Had multiple physical, psychological complications as a result of that. Our early studies were looking at things like, desire for death, and syndromal depression, and screening for depression and anxiety, and will to live. That the wish to… Eric: Complicated. Harvey: Complicated. Eric: So how do you do that?